Le Lézard
Classified in: Health, Business
Subjects: SVY, ECO, CFG

Canadians invited to share their views with the Advisory Council on the Implementation of National Pharmacare


Advisory Council launches its online consultations on how to move forward toward a national pharmacare

OTTAWA, July 20, 2018 /CNW/ - Prescription drug prices in Canada are among the highest in the developed world. Canada's patchwork of drug coverage leaves many Canadians facing significant barriers to getting the prescription drugs they need. In Budget 2018, the Government of Canada announced the creation of the Advisory Council on the Implementation of National Pharmacare, which was formally launched last month.  

All Canadians, including patients, and interested stakeholders are invited to take part in the work of the Council by sharing their views on what national pharmacare might look like. Today, the Council's chair, Dr. Eric Hoskins, announced the launch of the Council's online consultation.  

Canadians can provide their views on national pharmacare through an online questionnaire, as well as by providing written submissions to the Council. They can also engage in the discussion through an online discussion forum.

Feedback from Canadians will help shape the Council's independent report to the Federal Government, to be presented in spring 2019. The report will provide the Government with recommendations and a plan on how to move forward on national pharmacare.

Canadians are also invited to read the accompanying discussion paper, which is a starting point for the Council's dialogue with Canadians about the implementation of national pharmacare.

The Council looks forward to hearing from Canadians on this important issue. The online consultations will close on September 28, 2018.

Quick Facts

Quotes

"Hearing directly from Canadians will be critical as we work to find the best path forward to a national pharmacare plan. I invite each and every Canadian to participate in the consultation process by sharing your vision of pharmacare and letting us know how it could work to the benefit of all Canadians."

Dr. Eric Hoskins
Chair of the Advisory Council on the Implementation of National Pharmacare

"I encourage all Canadians to participate in this consultation. Their views and feedback will inform the Council's recommendations in support of better access to prescription medication for Canadians."

The Honourable Ginette Petitpas Taylor
Minister of Health

"We are committed to making prescription medications more accessible and more affordable, so that all Canadians are able to get the medicines they need. The ideas and insights people share during this important consultation will help us deliver a national Pharmacare program that works for Canada, and for Canadians."

The Honourable Bill Morneau
Minister of Finance

Associated Links

Canada.ca/Pharmacare 
Council's online consultation platform  

 

SOURCE Health Canada


These press releases may also interest you

at 05:30
Cato Networks, the SASE leader, announced a new SASE throughput record here at the Porsche Studio Ginza ahead of the 2024 Tokyo E-Prix, achieving 10 Gbps without hardware upgrades. At 10 Gbps, Cato became the first SASE platform to compete not only...

at 05:00
TAL Education Group ("TAL" or the "Company") , a smart learning solutions provider in China, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year 2024 ended February 29, 2024, before the market...

at 04:25
Ademi LLP is investigating Doma  for possible breaches of fiduciary duty and other violations of law in its transaction with Title Resources Group. ...

at 04:00
U Power Limited (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China, today announced that the Company held an extraordinary general meeting of...

at 04:00
Tonight on BBC1, REMY founder Abeer Iqbal, entered the Den, and despite intense grilling and no investment, left with a six-figure job offer from Peter Jones. ...

at 04:00
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company ("Chemours" or "the Company") and certain of its officers....



News published on and distributed by: